Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes
Related Experiment Video
Updated: Aug 10, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 15, 2011
C Venkataraman1, R L Chelvarajan, J C Cambier
1Department of Microbiology and Immunology and Sanders-Brown Center on Aging, University of Kentucky, Lexington 40536, USA.
Insights
Protein kinase A (PKA) activation inhibits B cell proliferation by inducing apoptosis. However, the cytokine IL-4 protects B cells from PKA
Area of Science:
- Immunology
- Cell Biology
Background:
- Protein kinase A (PKA) activation inhibits B cell antigen receptor (BCR) induced proliferation.
- PKA activation leads to B cell apoptosis and reduced growth response.
Purpose of the Study:
- To investigate the protective role of IL-4 against PKA-mediated inhibition of BCR signaling.
- To elucidate the mechanisms by which IL-4 rescues B cells from PKA-induced apoptosis and growth arrest.
Main Methods:
- Studied the effects of PKA activation on B lymphocytes, including BCR stimulation and cytokine treatment.
- Assessed B cell proliferation, apoptosis, and the expression of key signaling molecules like Bcl-xL.
- Investigated the impact of PKA on phospholipase Cgamma (PLCγ) activation and calcium mobilization.
Main Results:
- PKA activation induced apoptosis and inhibited BCR-induced proliferation, an effect rescued by IL-4.
- IL-4 prevented PKA-mediated apoptosis and growth arrest by restoring Bcl-xL expression.
- IL-4 did not overcome PKA-induced blockade of BCR-mediated calcium mobilization.
Conclusions:
- IL-4 protects B cells from PKA-mediated negative effects by modulating late-stage BCR signaling events.
- The protective mechanism of IL-4 involves the restoration of Bcl-xL expression, crucial for cell survival.
- PKA's inhibitory effects on BCR signaling in B cells differ from its effects in T cells and neutrophils.
Abstract:
Activation of protein kinase A (PKA) in B lymphocytes prior to the ligation of the B cell antigen receptor (BCR) results in a profound inhibition of BCR induced proliferation. The major effect of increased PKA activity in B lymphocytes was the induction of apoptosis leading to a reduced BCR induced growth response. The growth promoting cytokine IL-4 rescued B lymphocytes from PKA mediated negative effects. IL-4 protected BCR stimulated cells from PKA mediated inhibition primarily by preventing apoptosis and growth arrest. PKA-activation caused a downregulation of anti-IgM induced expression of Bcl-xL protein, that was restored by IL-4. Previous studies have shown that PKA-activation blocks BCR induced phospholipase Cgamma-activation and calcium mobilization. IL-4 was unable to overcome the block in anti-IgM mediated calcium mobilization due to PKA-activation. B cell apoptosis induced by PKA-activation was also seen in CD72 stimulated cells, although CD72 mediated B-lymphocyte proliferation was not affected. PKA mediated block in phospholipase gamma-activation and calcium mobilization were not due to alterations in the activation of tyrosine kinases lyn, blk and syk. Moreover, BCR mediated tyrosine phosphorylation of PLC gamma2 and CD19 were also unaffected by cAMP accumulation. These observations are in contrast to the ability of PKA to drastically reduce the activity of ZAP-70 and syk in T lymphocytes and neutrophils, respectively. The IL-4 mediated protection appears to be due to a change in late events in BCR signaling, which are important for Bcl-xL expression.
More Related Videos
09:26In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
08:26The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity
Published on: December 14, 2016
Related Concept Videos
Cell-mediated Immune Responses
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cells of the Adaptive Immune Response
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...